IP Library › Assignment 008128/0097
Patent Assignment
Reel/Frame 008128/0097

Assignment of Assignor's Interest

Recorded: 1996-05-06 Pages: 26
Assignor
ALLERGAN, INC.
Executed: 1996-01-17
Assignee
ALLERGAN
8301 MARS DRIVE, WACO, TEXAS, 76712
Covered Properties (96)
Apparatus and Method for Disinfecting a Contact Lens and Detecting the Presence of an Oxidative Disinfectant
Application: 07/588,086 →
2-Decarboxyl-2-Hydroxyalkyl-5-Trans Prostaglandin F Derivatives
Application: 07/652,179 →
Process and Intermediates for Preparing Compounds Having a Disubstituted Acetylene Moiety and Retinoic Acid-Like Biological Activity
Patent: 5,717,094 →
Application: 07/731,162 →
Methods for Generating Chlorine Dioxide and Compositions for Disinfecting
Application: 07/765,219 →
Stable Solution of Hyaluronate in a Balanced Salt Medium
Application: 07/798,835 →
Method for Reducing Intraocular Pressure in the Mammalian Eye by Administration of Muscarinic Antagonists
Patent: 5,716,952 →
Application: 07/853,374 →
Surgical Instrument with Drawer Loading Cassette System
Application: 07/940,659 →
Method of Treating Ocular Hypertension with 8-Epi Prostaglandins
Patent: 6,124,353 →
Application: 07/975,194 →
Contact Lens Disinfecting Solution Containing Sodium Chlorite and Polyvinyl Pyrrolidone
Application: 07/991,775 →
Methods and Compositions for Inhibiting Deposit Formation on Contact Lenses
Patent: 6,136,850 →
Application: 08/016,931 →
Polysiloxanes, Methods of Making Same and High Refractive Index Silicones Made from Same
Application: 08/048,092 →
5-Trans-Alcohols and Their Use as Ocular Hypotensives
Patent: 5,656,635 →
Application: 08/074,104 →
Multiple Botulinum Toxins for Treting Neuromuscular Disorders and Conditions
Application: 08/075,032 →
Treatment of Neuromuscular Disorders and Conditions with Different Botulinum Serotype
Application: 08/075,048 →
Iol Structured for Post-Operative Re-Positioning and Method for Post-Operative Iol Re-Positioning
Patent: 5,571,177 →
Application: 08/077,810 →
Enzyme Compositions and Methods for Contact Lens Cleaning
Application: 08/079,195 →
Method of Laser Photoablation of Lenticular Tissue for the Correction of Vision Problems
Patent: 6,322,556 →
Application: 08/103,089 →
Nucleic Acis Encoding Human EP3 Prostaglandin Receptor
Patent: 6,057,433 →
Application: 08/155,005 →
Intraocular Pressure Reducing 15-Acyl Prostaglandins
Application: 08/175,476 →
Nonaqueous Fluorinated Drug Delivery Suspensions
Patent: 6,458,376 →
Application: 08/179,508 →
Disinfection Formulations and Methods Using D-Enantiomeric Anti-Microbial Peptides
Patent: 5,549,894 →
Application: 08/182,994 →
Compositions and Methods to Disinfect Contact Lenses
Patent: 6,338,847 →
Application: 08/203,837 →
Method for Disinfecting Contact Lens with Catalase Compositions
Patent: 5,549,891 →
Application: 08/223,340 →
Phospholipid Preservation of Hydrogen Peroxide-Containing Compositions
Application: 08/226,186 →
Compositions and Methods for Identifying a Solution
Patent: 5,578,240 →
Application: 08/227,707 →
Substituted Thiazole Sulfonamides as Antiglaucoma Agents
Patent: 5,519,040 →
Application: 08/236,720 →
Biostable Corneal Implants and Methods for Producing Same
Application: 08/237,088 →
Base Storage of Handset's Base Registrations
Patent: 5,509,052 →
Application: 08/248,971 →
Iol for Optimal Capsular Bag Fit
Patent: 5,578,082 →
Application: 08/250,726 →
Contact Lens Cleaning Compositions with Solubilized Polymers
Application: 08/265,464 →
Reusable Cartridge Assembly for a Phaco Machine
Patent: 5,533,976 →
Application: 08/276,085 →
In-The-Eye Use of Chlorine Dioxide-Containing Compositions
Patent: 5,736,165 →
Application: 08/277,718 →
Method for Reducing Filtrate Waste in a Manufacturing Process of a Pharmaceutical Product Containing Benzalkonium Chloride
Patent: 5,550,163 →
Application: 08/285,079 →
Resealable Contact Lens Pouch and Method of Using
Patent: 5,598,919 →
Application: 08/291,785 →
Use of 2-Substituted-Thiazolidine-4-Carboxylic Acids for Treatment of Cataract
Patent: 5,589,464 →
Application: 08/316,596 →
Disubstituted Acetylenes Bearing Heteroaromatic and Heterobicyclic Groups Having Retinoid Like Activity
Patent: 5,602,130 →
Application: 08/323,174 →
Method for Preparing Esters of Halonicotinic Acids
Patent: 5,659,042 →
Application: 08/329,023 →
Combinations of Prostaglandins and Brimonidine or Derivatives Thereof for the Treatment of Glaucoma
Application: 08/330,050 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,552,403 →
Application: 08/332,029 →
Method for Reducing Intraocular Pressure in the Mammalian Eye by Administration of Chloride Channel Blockers
Patent: 5,559,151 →
Application: 08/346,660 →
Cast Molding of Intraocular Lenses
Patent: 5,620,720 →
Application: 08/346,974 →
Method for Reducing Intraocular Pressure in the Mammalian Eye by Administration of Guanylate Cyclase Inhibitors
Patent: 5,602,143 →
Application: 08/352,018 →
Novel 7-(5-Substituted Cyclopentyl) and (5-Substituted Cyclopentenyl) Heptyl Alcohols, Heptylamines and Heptanoic Acid Amides, and Method of Lowering Intraocular Pressure in the Eye of a Mammal by Administration of These Novel Compounds
Patent: 5,552,434 →
Application: 08/355,463 →
Specific Volume Dispenser
Patent: 5,582,330 →
Application: 08/365,571 →
Disinfection of Contact Lenses Using Superoxide
Application: 08/366,166 →
Acetylenes Disubstituted with a 5 Oxo Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,618,943 →
Application: 08/366,167 →
Acetylenes Disubstituted with a 5 Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,514,825 →
Application: 08/366,168 →
Acetylenes Disubstituted with a 5 Substituted Tetrahydronaphthyl Group and with an Aryl of Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,599,967 →
Application: 08/366,169 →
Acetylenes Disubstituted with Hydroxyaryl and Aryl or Heteroaryl Groups Having Retinoid-Like Biological Activity
Patent: 5,498,795 →
Application: 08/366,170 →
Acetylenes Disubstituted with a 5 Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Groups Having Retinoid-Like Biological Activity
Patent: 5,543,534 →
Application: 08/366,172 →
Acetylenes Disubstituted with 2-Tetrahydropyranoxyaryl and Aryl or Heteroaryl Groups Having Retinoid-Like Biological Activity
Patent: 5,534,641 →
Application: 08/366,173 →
Oxiranyls Disubstituted with a Phenyl Group and a Substituted Chromanyl or Tetrahydroquinolinyl Group Having Retinoid Like Activity
Patent: 5,556,996 →
Application: 08/366,174 →
Acetylenes Disubstituted with a 5-Amino or Substituted 5-Amino Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,489,584 →
Application: 08/366,182 →
Acetylenes Disubstituted with a 5 Substituted Dihydronaphthyl Group and with an Aryl or Heteroaryl Group Having Retinoid-Like Biological Activity
Patent: 5,618,931 →
Application: 08/366,183 →
Substituted Acetylenes Having Retinoid-Like Biological Activity
Patent: 5,648,514 →
Application: 08/366,193 →
Non-Acidic Cyclopentane Heptanoic Acid, 2-Cycloalkyl or Arylalkyl Derivatives as Therapeutic Agents
Patent: 5,607,978 →
Application: 08/371,339 →
Methods and Means for Control of Proliferation of Remnant Cells Following Surgery
Patent: 5,627,162 →
Application: 08/374,360 →
7-[Carboxyalkyl or Alkenyl]-6-[Alkyl or Alkenyl] 3-Oxo-2,4- Dioxobicyclo-[3.2.1] Octane and Derivatives Thereof
Patent: 5,516,791 →
Application: 08/378,414 →
Phacoemulsification System Having Ultrasonic Power Controlled by Aspiration Vacuum Sensor
Patent: 5,700,240 →
Application: 08/378,533 →
Diagnostic Apparatus for Determining Precorneal Retention Time of Ophtalmic Formulations
Application: 08/378,543 →
Pharmaceutical Compositions and Method for Administering 3 and 4-Substituted 2(5H)-Furanones to a Mammal for Inhibiting Bone Lose
Patent: 5,541,221 →
Application: 08/380,482 →
Deformable Lens Insertion Apparatus and Method
Patent: 5,562,676 →
Application: 08/382,948 →
Acetylenes Disubstituted with a Heteroaromatic Group and a Substitued Phenyl Group Having Retinoid Like Activity
Patent: 5,516,904 →
Application: 08/384,886 →
Acetylenes Disubstituted with a Heteroaromatic Group and a 2-Substituted Chromanyl, Thiochromanyl or 1,2,3,4 - Tetrahydroquinolinyl Group Having Retinoid-Like Activity
Patent: 5,534,516 →
Application: 08/385,000 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,561,132 →
Application: 08/390,265 →
Process for Preparing 4,4-Dialkyl-6-Halo-Chromans or Thiochromans Useful as Pharmaceutical Intermediates
Patent: 5,519,150 →
Application: 08/396,848 →
Multiple Fluid Dispensing Device for Low Surface Tension Formulations
Patent: 5,564,596 →
Application: 08/405,143 →
Intraocular Lenses and Methods for Producing Same
Patent: 5,527,415 →
Application: 08/412,657 →
[4-(1,2-Epoxycyclohexanyl)But-3-En-1-Ynyl]Aromatic and Heteroaromatic Acids and Derivatives Having Retinoid-Like Biological Activity
Patent: 5,618,836 →
Application: 08/419,626 →
Syringe Flange Adapter and Method
Patent: 5,554,133 →
Application: 08/421,646 →
Method of Treatment with Compounds Having Selective Agonist-Like Activity on Rxr Retinoid Receptors
Patent: 6,627,652 →
Application: 08/425,558 →
Method for Regulating Intraocular Pressure During Endophtalmic Surgery
Patent: 5,649,905 →
Application: 08/444,423 →
Cyclopentane(Ene)Heptenoic or Heptanoic Acids and Derivatives Thereof Useful as Therapeutic Agents
Patent: 5,587,391 →
Application: 08/445,842 →
Compositions and Methods for Contact Lens Disinfecting
Patent: 5,660,862 →
Application: 08/449,442 →
Intraocular Lenses and Methods for Producing Same
Patent: 5,895,609 →
Application: 08/455,763 →
Acetylenes Disubstituted with a Thienyl or Furyl Group and a 2-Substituted Chromanyl, Thiochromanyl or 1,2,3,4 - Tetrahydroquinolinyl Group Having Retinoid-Like Activity
Patent: 5,599,819 →
Application: 08/458,389 →
Phenyl or Heteroaryl and Tetrahydronaphthyl Substituted Diene Compounds Having Retinoid Like Biological Activity
Patent: 5,602,135 →
Application: 08/458,394 →
Methods for Using (2-Imidazolin-2-Ylamino) Quinoxaline Derivatives
Patent: 5,587,376 →
Application: 08/458,949 →
Acetylenes Disubstituted with a Heteroaromatic Group and a 2- Substituted Chromanyl, Thiochromanyl or 1,2,3,4 - Tetrahydro- Quinolinyl Group Having Retinoid-Like Activity
Patent: 5,616,597 →
Application: 08/460,477 →
Phenyl or Heteroaryl and Tetrahydronaphthyl Substituted Diene Compound Having Retinoid Like Biological Activity
Patent: 5,696,162 →
Application: 08/460,487 →
Disubstituted Acetylenes Bearing Heterobicyclic Groups and Heteroaromatic or Phenyl Groups Having Retinoid Like Activity
Patent: 5,677,451 →
Application: 08/466,003 →
Disubstituted Acetylenes Bearing Heterobicyclic Groups and Heteroaromatic or Phenyl Groups Having Retinoid Like Activity
Patent: 5,663,347 →
Application: 08/466,005 →
Reinforced Compositions and Lens Bodies Made from Same
Patent: 5,623,029 →
Application: 08/473,393 →
Novel 1,3-Benzodioxole and 1,2-Dialkoxybenzene Derivatives as Ocular Hypotensive Agents
Patent: 5,654,329 →
Application: 08/485,521 →
Method and Apparatus for Folding of Intraocular Lenses
Patent: 5,653,753 →
Application: 08/487,762 →
EP2-Recptor Agonists as Agents for Lowering Intraocular Pressure
Patent: 5,698,598 →
Application: 08/511,182 →
Compositions and Methods for Destroying Hydrogen Peroxide
Application: 08/515,756 →
Intraocular Pressure Reducing 15-Acyl Prostaglandins
Patent: 5,574,066 →
Application: 08/531,488 →
Dropwise Liquid Dispensing System Particularly Suitable for Liquids Having Low Surface Tension
Patent: 5,664,704 →
Application: 08/534,288 →
Bimodal Molecular Weight Hyaluronate Formulations and Methods for Using Same
Patent: 6,107,347 →
Application: 08/536,408 →
Conformationally Rigid Bicycle and Adamantane Derivatives Useful as ALPHA2-Adrenergic Blocking Agents
Patent: 5,731,337 →
Application: 08/538,694 →
Deformable-Elastic Intraocular Lens
Patent: 36,150 →
Application: 08/538,757 →
Acetylenes Disubstituted with a 5 Substituted Tetrahydronaphthyl Group and with an Aryl or Heteroaryl Groups Having Retinoid-Like Biological Activity
Patent: 5,723,620 →
Application: 08/552,813 →
Novel 7-(5-Substituted Cyclopentyl) and (5-Substituted Cyclopentenyl) Heptyl Alcohols, Heptylamines and Heptanoic Acid Amides, and Method of Lowering Intraocular Pressure in the Eye of a Mammal by Administra- Tion of These Novel Compounds
Patent: 5,674,910 →
Application: 08/572,437 →
Horizontal Instrument for Measuring Torticollis
Patent: 430,296 →
Application: 29/040,336 →
Curved Light Bar
Patent: 752,465 →
Application: 29/490,724 →
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 9, 2003
From: ALLERGAN, INC.; ALLERGAN SALES, LLC; ALLERGAN PHARMACEUTICALS; ALLERGAN WACO
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 014162/0161 →
Assignment of Assignor's Interest Jun 25, 2003
From: ALLERGAN, INC.; ALLERGAN SALES, LLC; ALLERGAN PHARMACEUTICALS, INC.; HEYER-SCHULTE CORP.
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 014201/0976 →
Assignment of Assignor's Interest Jun 22, 2004
From: ALLERGAN, INC.
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 014763/0419 →
Security Agreement Jul 28, 2004
From: ADVANCED MEDICAL OPTICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 014910/0177 →
Security Agreement Jul 28, 2004
From: ADVANCED MEDICAL OPTICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 014901/0704 →
Security Agreement Jul 29, 2004
From: ADVANCED MEDICAL OPTICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 014914/0692 →
Merger Jul 5, 2006
From: ALLERGAN
To: ALLERGAN SALES, INC.
Reel/Frame 017870/0561 →
Merger Jul 5, 2006
From: ALLERGAN SALES, INC.
To: ALLERGAN SALES, LLC
Reel/Frame 017870/0686 →
Assignment of Assignor's Interest Jul 5, 2006
From: ALLERGAN SALES, LLC
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 017870/0822 →
Assignment of Assignor's Interest Mar 5, 2007
From: ALLERGAN
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 018961/0054 →
Release of Security Interest at Reel/Frame No. 13203/0039 Apr 4, 2007
From: BANK OF AMERICA, N.A.
To: ADVANCED MEDICAL OPTICS, INC.; AMO HOLDINGS, INC. (FORMERLY KNOWN AS AMO HOLDINGS, LLC)
Reel/Frame 019111/0348 →
Release of Security Interest at Reel/Frame No. 14901/0704 Apr 4, 2007
From: BANK OF AMERICA, N.A.
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 019111/0461 →
Release of Security Interest at Reel/Frame No. 14910/0177 Apr 4, 2007
From: BANK OF AMERICA, N.A.
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 019111/0468 →
Assignment of Assignor's Interest May 18, 2007
From: ALLERGAN, LLC
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 019304/0984 →
Intellectual Property Security Agreement Jun 29, 2007
From: ADVANCED MEDICAL OPTICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 019501/0069 →
Merger Aug 16, 2007
From: VISION PHARMACEUTICALS L.P.
To: ALLERGAN SALES, INC.
Reel/Frame 019704/0331 →
Merger Aug 16, 2007
From: ALLERGAN SALES, INC.
To: ALLERGAN SALES, LLC
Reel/Frame 019704/0337 →
Doing Business as (Dba) Aug 16, 2007
From: VISION PHARMACEUTICALS L.P.
To: ALLERGAN
Reel/Frame 019704/0287 →
Release of Security Interest Feb 27, 2009
From: BANK OF AMERICA, N.A. AS ADMINISTRATIVE AGENT
To: ADVANCED MEDICAL OPTICS, INC.
Reel/Frame 022320/0427 →
Merger Jul 29, 2009
From: ADVANCED MEDICAL OPTICS, INC.
To: ABBOTT MEDICAL OPTICS INC.
Reel/Frame 023234/0277 →
Change of Name Sep 18, 2018
From: ABBOTT MEDICAL OPTICS INC.
To: JOHNSON & JOHNSON SURGICAL VISION, INC.
Reel/Frame 047568/0979 →